Expect MoRe®
Do MoRe®

Careers

Work With MiRus

At MiRus we give you the opportunity to develop your career based on your strengths and potential. MiRus is an early stage company with deep proprietary technology in both implants and surgical navigation. MiRus was started by a team of experienced entrepreneurs with a history of creating disruptive technologies and very successful, highly valued companies. 

CAREERS

Open Positions

MiRus Receives 2022 Pacesetter Award

May 3, 2022

MiRus is setting the pace as one of the fastest-growing companies in the metro Atlanta area with over 250% growth in the past two years ! Atlanta Business Chronicle 2022 Pacesetter Award ow.ly/Jy6a50IXUVZ

Read More

MiRus Announces Plans for Site of New Headquarters

December 2, 2021

MiRus announces plans for site of new headquarters with the purchase of the Franklin Gateway 6.72 acre property from the City of Marietta. The new headquarters will be a three-story facility comprising over 70,000 square feet. https://www.mariettaga.gov/CivicAlerts.aspx?AID=3474

Read More

MiRus Receives FDA 510(K) Clearance For
The Lowest Profile and Best-in-class Expandable Lumbar Interbody

August 31, 2021

ATLANTA- August 31, 2021 – MiRus LLC, the leading innovator in rhenium-based superalloy medical implants announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its IO™ Expandable Lumbar Interbody. The IO™ Expandable Lumbar Interbody can be utilized in both PLIF and TLIF procedures.  It features the lowest insertion profile […]

Read More

MiRus™ Raises $65 Million For Expansion of Rhenium-based Medical Devices

July 27, 2021

ATLANTA- July 27, 2021 – MiRus LLC, a commercial stage life sciences company, has completed a highly oversubscribed funding round for growth of its spine and extremity portfolios and development of structural heart disease solutions using its proprietary Rhenium-based alloys (MoRe®).  The round was led by Mammoth Scientific and multi-generational family offices who have supported […]

Read More

Heart to Heart with Jay S. Yadav MD, Founder and CEO MiRus

July 14, 2021

“The best things in life are somewhat accidental,” says Dr. Jay Yadav. He should know. From aspiring to study astronomy to choosing medicine to work on cancer and then opting for cardiology and then innovating cardiovascular medical devices to save lives which led to being a serial entrepreneur, Dr. Yadav admits his path of success is a summation of “serendipitous” happenings in his life and his spontaneous reactions to these situations. In fact, the trend seems to have applied to the way he met his better-half, Marshalla, he says “I only met her one time at the hospital when I was a resident at Duke. Our paths may never have crossed again if I had not immediately asked her to have dinner.”

Read More

Mammoth Scientific Launches $100 Million Venture Capital Fund

July 13, 2021

Mammoth™ Scientific, a health science and technology venture capital firm, announced the launch of a $100 million venture capital fund today. Co-founders Dr. Jay Yadav, Tommy Martin, Kim Mackrill, Dr. Matthew McGirt and Jud Mackrill provide venture capital for health science and technology companies who are maturing beyond seed rounds “As veterans in the startup world, we have first-hand knowledge of the […]

Read More

MiRus™ announced today that Mark Faucett has joined the company’s Leadership Team as Vice President of Business Development effective June 1, 2021.

July 6, 2021

Mr. Faucett has most recently served as founder and CEO of Capital Surgical Solutions, a medical device distributorship. He brings over 30 years of experience successfully growing sales teams by pairing proven leadership achievements in the medical device space with the ability to form key partnerships, developing high-performing teams, and creating compelling sales strategies in solution-oriented environments.

Read More

MiRus™ Launches MoRe® Promise- a Lifetime Limited Warranty for its Molybdenum-Rhenium Superalloy Rod.

February 23, 2021

MiRus announced today that they will offer a LIFETIME LIMITED WARRANTY on its Molybdenum-Rhenium ( MoRe®) superalloy rod technology. The warranty will cover full replacement of the MoRe® Rod and corresponding MiRus hardware used in spinal fusion cases should the MoRe® Rod fracture. The warranty will cover all thoracolumbar MoRe® rods implanted as part of the EUROPA™ Pedicle Screw System supplied by MiRus in the United States effective March 1, 2021.

Read More

MiRus Online Exhibitor at KASS July 2-3, 2020

June 22, 2020

MiRus is pleased to participate in the 15th Annual Virtual Meeting of the Korean American Spine Society. July 2-3, 2020. Visit the online exhibitor showcase to learn more about our growing MoRe-inforced product portfolio.

Read More

MiRus™ Announces First Clinical Use of the MiRus™ 3DR™ Printed Lumbar Interbody Fusion System.

June 11, 2020

MiRus is pleased to announce that it received FDA 510(k) clearance for its 3DR™ (Randomized) Printed Lumbar Interbody Fusion System which consists of the CALLISTO 3DR™ PLIF, HYPERION 3DR™ TLIF, CALYPSO 3DR™ LLIF and the ANTARES 3DR™ ALIF.

Read More